Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Vaccine|November 10, 2020
HPV cervical infections and serological status in vaccinated and unvaccinated womenCarmen Lía Murall, Bastien Reyné, Christian Selinger, et al.
Idcases|September 19, 2022
Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case reportIlkay Başak Uysal, Vanina Boué, Carmen Lia Murall, et al.
Frontline Gastroenterology|October 19, 2023
Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement projectSamantha Baillie, Jimmy K Limdi, Ash Bassi, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort studyShaji Sebastian, Christopher Black, Daniela Pugliese, et al.
Molecular Ecology|September 4, 2022
Does exposure to different menstrual products affect the vaginal environment?Nicolas Tessandier, Ilkay Başak Uysal, Baptiste Elie, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Nature Communications|January 11, 2018
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapyAmeya R Kirtane, Omar Abouzid, Daniel Minahan, et al.
Pageof 8